Atorvastatin is used as lipid-lowering agents used in hyperlipidaemia condition.Atorvastatin selectively and competitively inhibits the hepatic enzyme HMG-CoA reductase. (4) As HMG-CoA reductase is responsible for converting HMG-CoA to mevalonate in the cholesterol biosynthesis pathway, this results in a subsequent decrease in hepatic cholesterol levels and decreases blood cholesterol level. Figure 2 : Structureofatorvastatin (5) Atorvastatin iswhiteoralmostwhite,crystallinepowder.Solubilityisgiveninpractically insoluble in water, soluble in methanol, slightlysolublein methylenechloride.
Hypertension frequently coexists with hyperlipidaemia and both are considered to be major risk factors for developing cardiac disease ultimately resulting in adverse cardiac events. This clustering of risk factors is potentially due to a common mechanism. Further, patient compliance with the management of hypertension is generally better than patient compliance with hyperlipidaemia. It would therefore be advantageous for patients to have a single therapy which treats both of these conditions with help of fixed dose combination of Irbesartan and atorvastatin. (6,7)
The review of literature regarding quantitative analysis of Irbesartan and atorvastatinrevealed that no attempt was made to develop analytical methods for Irbesartan and atorvastatin. Some spectrometric methods and chromatographic methods have been reported for theestimation of the individual drugs.The focus of the present study was to develop and validate a rapid, stable, specific, and economic spectroscopic method for the estimation of Irbesartan and atorvastatinin Synthetic mixture. (8, 9) MATERIALS AND METHODOLOGY:  Atorvastatin and Irbesartan were obtained as gift samples from S Kant pharmaceuticals and CTX life science Surat. Synthetic Mixture contain 20mg of Atorvastatin and 160mg of Irbesartan.  A double beam UV/Visible spectrophotometer (Shimadzu model 2450, Japan) with spectral width of 2 nm, 1 cm quartz cells was used to measure absorbance of all the solutions.  Spectra were automatically obtained by UV-Probe system software.  An analytical balance (Sartorius CD2250, Gottingen, Germany) was used for weighing the samples.  Sonicator(D120/2H, TRANS-O-SONIC)  Class 'A' volumetric glassware were used (Borosillicte)
Standard solutionofIrbesartan (IRB) Preparation of stock solution of IRB
Accurately weighed quantity of Irbesartan 10 mg was transferred to 100 ml volumetric flask, dissolved and diluted up to mark with methanol to give a stock solution having strength of 100μg/ml. Preparation of stock solution of ATR Accurately weighed quantity of Atorvastatin 10mg was transferred to 100 ml volumetric flask, dissolved and diluted up to mark with methanol to give a stock solution having strength of 100μg/ml.
Preparation of standard mixture solution
From the stock solution of IRB take 3.2ml and from stock solution of ATR take 0.4ml and transferred in to 10ml volumetric flask and diluted up to mark with methanol to give a solution having strength of IRB was 32 μg/ml and ATR was 4 μg/ml.
Preparation of test solution
From the stock solution of IRB take 3.2ml and from stock solution of ATR take 0.4ml and transferred in to 10ml volumetric flask and diluted up to mark with methanol to give a solution having strength of IRB was 32 μg/ml and ATR was 4 μg/ml. 
Precision I. Intraday precision
ThedataforintradayprecisionforcombinedstandardsolutionofIRB and ATRis presented in Table 2 The%R.S.D wasfoundto be 0.39 -0.65% forIRB and 0.34 -0.68% for ATR. These%RSDvaluewasfoundtobelessthan±1.0indicatedthatthemethod is precise. 
II. Interday precision
ThedataforinterdayprecisionforcombinedstandardsolutionofIRB and ATRis presented in Table 3 The% R.S.D was foundto be0.41-0.84% forIRB and0.38-0.89%for ATR. These%RSDvaluewasfoundtobelessthan±1.0indicatedthatthemethod is precise. Table 3 Interday precision data for estimation ofIRB andATR*(n=3)
Accuracy
Accuracyofthemethodwasdeterminedbyrecoverystudyfromsynthetic mixture at threelevels (80%, 100%, and 120%) of standard addition. The% recoveryvalues aretabulated in Table 4and 5 PercentagerecoveryforIRB andATRbythismethodwasfoundintherange of98.95 to 101.56% and99.16 to 100.5%, respectively, Thevalueof%RSDwithinthelimitindicatedthatthemethodisaccurateand percentagerecoveryshows that thereis no interferencefrom the excipients. 
Conc. (μg/ml)

Robustness andRuggedness
Theobtained Ruggedness andRobustness results arepresented in table7 The% R.S.D was foundto be 0.22-0.94% forIRB and0.33-0.86% for ATR. These%RSDvaluewasfoundtobelessthan±1.0indicatedthatthemethod is precise. No significant changes in the spectrums were observed, proving that the developed method is ruggedand robust. 
